Section 4.2 for those who want to read up about best disclosure practice with Medical Phase 1-111 trial results.https://www.asx.com.au/documents/research/Code_of_Best_Practice_for_Reporting_by_Life_Science_Companies.pdf
I’m my opinion the company has told the independent bio-statistical company to delay the results until after the Ards secondary endpoints release. Too much going on. But that is a complete guess. Facts are in the link.
Eight
Reg
Section 4.2 for those who want to read up about best disclosure...
-
- There are more pages in this discussion • 8,740 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
0.025(1.85%) |
Mkt cap ! $1.552B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.38 | $1.33 | $1.318M | 971.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 36130 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 97318 | 16 |
View Market Depth
| Last trade - 12.30pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |